Stable expression of infliximab in CRISPR/Cas9-mediated BAK1-deficient CHO cells.
Miao Z, Li Q, Zhao J, Wang P, Wang L, He HP, Wang N, Zhou H, Zhang TC, Luo XG.
Miao Z, et al. Among authors: wang l, wang p, wang n.
Biotechnol Lett. 2018 Aug;40(8):1209-1218. doi: 10.1007/s10529-018-2578-4. Epub 2018 Jun 18.
Biotechnol Lett. 2018.
PMID: 29915899